Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
BVAXF
Primary Symbol:
C.BIOV
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jan 31, 2022 7:46am
Test
How can you measure if a booster dose against covid is needed (or not)? The Hospital de Canarias has created a quick test to find out if a third dose of the covid vaccine is necessary
...more
(4)
•••
SnowBall123
X
View Profile
View Bullboard History
Comment by
SnowBall123
on Jan 30, 2022 7:34pm
RE:RE:RE:Here is a twist to the covid diagnostic tool
Awesome!
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(12)
•••
frankman
X
View Profile
View Bullboard History
Comment by
frankman
on Jan 30, 2022 4:17pm
RE:RE:Here is a twist to the covid diagnostic tool
He said there were a couple of countries but could not reveal them to me. Talks ongoing.
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jan 30, 2022 2:19pm
T cell
https://www.marketwatch.com/press-release/shortages-of-covid-19-tests-creates-accelerated-demand-for-new-diagnostic-technology-2021-11-09-101971242
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jan 30, 2022 1:13pm
No hype it’s just fact
https://www.labmedica.com/covid-19/articles/294790222/worlds-first-low-cost-disposable-covid-19-diagnostic-test-to-identify-t-cell-immune-response-to-sars-cov-2.html
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jan 29, 2022 12:27am
T cell
https://consumer.healthday.com/b-1-27-beyond-antibodies-vaccines-teach-your-immune-t-cells-to-fight-covid-long-term-2656474938.html
(4)
•••
SnowBall123
X
View Profile
View Bullboard History
Comment by
SnowBall123
on Jan 28, 2022 6:27pm
RE:Here is a twist to the covid diagnostic tool
Talking with less requirement countries isn't new, he said that many times in other interviews. Did he say what stage they're in for the talk?
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jan 28, 2022 3:41pm
Here is a twist to the covid diagnostic tool
Just got off the phone. They are also exploring a licensing deal with a royalty with other countries. The skin test faces less requirements in some counties. The only other known test requires a
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jan 28, 2022 1:41pm
CEO Passin just replied to me they are completing the annual
James said he would phone me later.
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Jan 28, 2022 11:52am
They are quite slim .19 up
The anon 20k ask they bought at .18 a few days ago and keeps pulling so they are welcome to sell at a loss. Lokk at the nothing shares behind. 0.20 2,500 1
...more
(328)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Jan 28, 2022 10:38am
BIOV GET THE POPCORN NEW 52 WK LOW @175 SHORT MAKE MONEY
KEEP the pressure shorts Symbol Issue Name Shares Net Change Date $BIOV.CN BIOVAXYS TECHNOLOGY CORP. 133,866 76,103
...more
(32)
•••
annwarw
X
View Profile
View Bullboard History
Comment by
annwarw
on Jan 27, 2022 2:42pm
RE:RE:RE:On that note BIOV will start human tumour trials
FDA is only looking at minimal factors as it only involves sample taking.
(32)
•••
annwarw
X
View Profile
View Bullboard History
Comment by
annwarw
on Jan 27, 2022 2:37pm
RE:RE:On that note BIOV will start human tumour trials
I think it might be the FDA approval of the covid diagnostic tool. A formality.
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Jan 27, 2022 2:04pm
Now gap up to .195 .20
0.20 12,500 2 0.195 2,500 2 0.185 500 1
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income